Research And Markets Research And Markets
0 CHECKOUT

Search for: "Alzheimer's Disease – The Evaluation & Management of Dementia 2013"

Aricept (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Aricept (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Aricept (Alzheimer’s Disease) - Forecast and Market...

Published:  September 2013
Price:  From EURUSDGBP

Namenda (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Namenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Namenda (Alzheimer’s Disease) - Forecast and Market...

Published:  July 2013
Price:  From EURUSDGBP

Exelon (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Exelon (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Exelon (Alzheimer’s Disease) - Forecast and Market...

Published:  September 2013
Price:  From EURUSDGBP

Razadyne/Reminyl (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Razadyne/Reminyl (Alzheimer’s Disease) -...

Published:  September 2013
Price:  From EURUSDGBP

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  September 2016
Price:  From EURUSDGBP

Namenda XR (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Namenda XR (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Namenda XR (Alzheimer’s Disease) - Forecast and...

Published:  July 2013
Price:  From EURUSDGBP

TRx0237 (Alzheimer's Disease) - Forecast and Market Analysis to 2022

TRx0237 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TRx0237 (Alzheimer’s Disease) - Forecast and Market...

Published:  July 2013
Price:  From EURUSDGBP

Arimenda (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Arimenda (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Arimenda (Alzheimer’s Disease) - Forecast and Market...

Published:  July 2013
Price:  From EURUSDGBP

MK-8931(Alzheimer's Disease) - Forecast and Market Analysis to 2022

MK-8931(Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “MK-8931(Alzheimer’s Disease) - Forecast and Market...

Published:  July 2013
Price:  From EURUSDGBP

EVP-6124 (Alzheimer's Disease) - Forecast and Market Analysis to 2022

EVP-6124 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “EVP-6124 (Alzheimer’s Disease) - Forecast and Market...

Published:  July 2013
Price:  From EURUSDGBP

Lu AE58054 (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Lu AE58054 (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lu AE58054 (Alzheimer’s Disease) - Forecast and...

Published:  July 2013
Price:  From EURUSDGBP

Solanezumab (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Solanezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Solanezumab (Alzheimer’s Disease) - Forecast and...

Published:  July 2013
Price:  From EURUSDGBP

Gantenerumab (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Gantenerumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gantenerumab (Alzheimer’s Disease) - Forecast...

Published:  July 2013
Price:  From EURUSDGBP

Crenezumab (Alzheimer's Disease) - Forecast and Market Analysis to 2022

Crenezumab (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Crenezumab (Alzheimer’s Disease) - Forecast and...

Published:  July 2013
Price:  From EURUSDGBP

Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables...

Published:  February 2015
Price:  From EURUSDGBP
EURUSDGBP

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued...

Published:  November 2013
Price:  From EURUSDGBP

Netter's Neurology. Edition No. 2. Netter Clinical Science

Netter's Neurology, 2nd Edition, by Drs. H. Royden Jones, Jayashri Srinivasan, Gregory J. Allam, and Richard A. Baker, uses visually rich Netter artwork to efficiently provide you with a concise overview...

Published:  September 2011
Price:  EURUSDGBP

The Netter Collection of Medical Illustrations: Nervous System, Volume 7, Part 1 - Brain. Edition No. 2. Netter Green Book Collection

Brain, Part 1 of The Netter Collection of Medical Illustrations: Nervous System, 2nd Edition, provides a highly visual guide to this complex organ, from basic neurodevelopment, neuroanatomy, neurophysiology,...

Published:  March 2013
Price:  EURUSDGBP

Positron Emission Tomography (PET) Markets

The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment Continuous...

Published:  July 2011
Price:  From EURUSDGBP
Loading Indicator